2nd Quarter - Termination
ARTEMIS STRATEGIES for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$20,000
Expenses
—
Terminated
Jun 30, 2008
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues relating to the US-Israel Trade USTR Special 301 Report
Foreign entity interest: Teva Pharmaceuticals USA is a wholly owned subsidiary of Teva Pharmaceuticals based in Israel
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAVIS | — |
| DANA DEBEAUMONT | — |
| JAMES E DORNAN | — |
| TIMOTHY F POWERS | — |
| ARI STORCH | — |
| ARI JONATHAN STRAUSS | — |
| KATHERINE YEHL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.